Prof. Dr. Eliane J. Müller

Founder & Chair of the Board

Therapeutic Areas

Drug	Indication	Phase
NEOLIVER Consortium Participation	Personalized Bioprinted Liver for Clinical Use	Research/Pre-clinical
CnT-NX-EX Media Development	Long-term expansion of primary epithelial cells (e.g., keratinocytes)	Commercial
Higher Certified Media Line	Support for clinical-grade cell therapy manufacturing	Commercial